Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T15:46:28.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    An NIH-wide notice about a terminology transition was added above the page, and the site revision label changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    1%
    Check dated 2026-10-20T14:54:10.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T15:12:51.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The Study Details page has had extensive study documents and historical metadata removed, including protocol, analysis plan, and investigator/publication references, leaving a leaner view of the trial's current status.
    Difference
    17%
    Check dated 2026-09-22T21:54:43.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 was added and the v3.6.6 tag was removed. This updates the page's version metadata.
    Difference
    0.0%
    Check dated 2026-09-15T22:05:59.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page without changing study details or layout.
    Difference
    0.0%
    Check dated 2026-09-01T19:16:32.000Z thumbnail image

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.